- IBDEI217 ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,32424,1,4,0)
- ;;=4^H35.373
- ;;^UTILITY(U,$J,358.3,32424,2)
- ;;=^5005664
- ;;^UTILITY(U,$J,358.3,32425,0)
- ;;=H35.33^^128^1660^22
- ;;^UTILITY(U,$J,358.3,32425,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32425,1,3,0)
- ;;=3^Angioid Streaks of Macula
- ;;^UTILITY(U,$J,358.3,32425,1,4,0)
- ;;=4^H35.33
- ;;^UTILITY(U,$J,358.3,32425,2)
- ;;=^5005649
- ;;^UTILITY(U,$J,358.3,32426,0)
- ;;=H35.711^^128^1660^7
- ;;^UTILITY(U,$J,358.3,32426,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32426,1,3,0)
- ;;=3^Central Serous Chorioretinopathy,OD
- ;;^UTILITY(U,$J,358.3,32426,1,4,0)
- ;;=4^H35.711
- ;;^UTILITY(U,$J,358.3,32426,2)
- ;;=^5005703
- ;;^UTILITY(U,$J,358.3,32427,0)
- ;;=H35.712^^128^1660^8
- ;;^UTILITY(U,$J,358.3,32427,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32427,1,3,0)
- ;;=3^Central Serous Chorioretinopathy,OS
- ;;^UTILITY(U,$J,358.3,32427,1,4,0)
- ;;=4^H35.712
- ;;^UTILITY(U,$J,358.3,32427,2)
- ;;=^5005704
- ;;^UTILITY(U,$J,358.3,32428,0)
- ;;=H35.713^^128^1660^9
- ;;^UTILITY(U,$J,358.3,32428,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32428,1,3,0)
- ;;=3^Central Serous Chorioretinopathy,Bilateral
- ;;^UTILITY(U,$J,358.3,32428,1,4,0)
- ;;=4^H35.713
- ;;^UTILITY(U,$J,358.3,32428,2)
- ;;=^5005705
- ;;^UTILITY(U,$J,358.3,32429,0)
- ;;=H35.421^^128^1660^19
- ;;^UTILITY(U,$J,358.3,32429,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32429,1,3,0)
- ;;=3^Microcystoid Degeneration or Retina,OD
- ;;^UTILITY(U,$J,358.3,32429,1,4,0)
- ;;=4^H35.421
- ;;^UTILITY(U,$J,358.3,32429,2)
- ;;=^5005675
- ;;^UTILITY(U,$J,358.3,32430,0)
- ;;=H35.422^^128^1660^20
- ;;^UTILITY(U,$J,358.3,32430,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32430,1,3,0)
- ;;=3^Microcystoid Degeneration or Retina,OS
- ;;^UTILITY(U,$J,358.3,32430,1,4,0)
- ;;=4^H35.422
- ;;^UTILITY(U,$J,358.3,32430,2)
- ;;=^5005676
- ;;^UTILITY(U,$J,358.3,32431,0)
- ;;=H35.423^^128^1660^21
- ;;^UTILITY(U,$J,358.3,32431,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32431,1,3,0)
- ;;=3^Microcystoid Degeneration or Retina,Bilateral
- ;;^UTILITY(U,$J,358.3,32431,1,4,0)
- ;;=4^H35.423
- ;;^UTILITY(U,$J,358.3,32431,2)
- ;;=^5005677
- ;;^UTILITY(U,$J,358.3,32432,0)
- ;;=H35.451^^128^1660^23
- ;;^UTILITY(U,$J,358.3,32432,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32432,1,3,0)
- ;;=3^Secondary Pigmentary Degeneration,OD
- ;;^UTILITY(U,$J,358.3,32432,1,4,0)
- ;;=4^H35.451
- ;;^UTILITY(U,$J,358.3,32432,2)
- ;;=^5005687
- ;;^UTILITY(U,$J,358.3,32433,0)
- ;;=H35.452^^128^1660^24
- ;;^UTILITY(U,$J,358.3,32433,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32433,1,3,0)
- ;;=3^Secondary Pigmentary Degeneration,OS
- ;;^UTILITY(U,$J,358.3,32433,1,4,0)
- ;;=4^H35.452
- ;;^UTILITY(U,$J,358.3,32433,2)
- ;;=^5005688
- ;;^UTILITY(U,$J,358.3,32434,0)
- ;;=H35.453^^128^1660^25
- ;;^UTILITY(U,$J,358.3,32434,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32434,1,3,0)
- ;;=3^Secondary Pigmentary Degeneration,Bilateral
- ;;^UTILITY(U,$J,358.3,32434,1,4,0)
- ;;=4^H35.453
- ;;^UTILITY(U,$J,358.3,32434,2)
- ;;=^5005689
- ;;^UTILITY(U,$J,358.3,32435,0)
- ;;=H35.381^^128^1660^16
- ;;^UTILITY(U,$J,358.3,32435,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32435,1,3,0)
- ;;=3^Toxic Maculopathy,OD
- ;;^UTILITY(U,$J,358.3,32435,1,4,0)
- ;;=4^H35.381
- ;;^UTILITY(U,$J,358.3,32435,2)
- ;;=^5005666
- ;;^UTILITY(U,$J,358.3,32436,0)
- ;;=H35.382^^128^1660^17
- ;;^UTILITY(U,$J,358.3,32436,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,32436,1,3,0)
- ;;=3^Toxic Maculopathy,OS
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI217 3748 printed Feb 18, 2025@23:46:07 Page 2
- IBDEI217 ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,32424,1,4,0)
- +2 ;;=4^H35.373
- +3 ;;^UTILITY(U,$J,358.3,32424,2)
- +4 ;;=^5005664
- +5 ;;^UTILITY(U,$J,358.3,32425,0)
- +6 ;;=H35.33^^128^1660^22
- +7 ;;^UTILITY(U,$J,358.3,32425,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,32425,1,3,0)
- +10 ;;=3^Angioid Streaks of Macula
- +11 ;;^UTILITY(U,$J,358.3,32425,1,4,0)
- +12 ;;=4^H35.33
- +13 ;;^UTILITY(U,$J,358.3,32425,2)
- +14 ;;=^5005649
- +15 ;;^UTILITY(U,$J,358.3,32426,0)
- +16 ;;=H35.711^^128^1660^7
- +17 ;;^UTILITY(U,$J,358.3,32426,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,32426,1,3,0)
- +20 ;;=3^Central Serous Chorioretinopathy,OD
- +21 ;;^UTILITY(U,$J,358.3,32426,1,4,0)
- +22 ;;=4^H35.711
- +23 ;;^UTILITY(U,$J,358.3,32426,2)
- +24 ;;=^5005703
- +25 ;;^UTILITY(U,$J,358.3,32427,0)
- +26 ;;=H35.712^^128^1660^8
- +27 ;;^UTILITY(U,$J,358.3,32427,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,32427,1,3,0)
- +30 ;;=3^Central Serous Chorioretinopathy,OS
- +31 ;;^UTILITY(U,$J,358.3,32427,1,4,0)
- +32 ;;=4^H35.712
- +33 ;;^UTILITY(U,$J,358.3,32427,2)
- +34 ;;=^5005704
- +35 ;;^UTILITY(U,$J,358.3,32428,0)
- +36 ;;=H35.713^^128^1660^9
- +37 ;;^UTILITY(U,$J,358.3,32428,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,32428,1,3,0)
- +40 ;;=3^Central Serous Chorioretinopathy,Bilateral
- +41 ;;^UTILITY(U,$J,358.3,32428,1,4,0)
- +42 ;;=4^H35.713
- +43 ;;^UTILITY(U,$J,358.3,32428,2)
- +44 ;;=^5005705
- +45 ;;^UTILITY(U,$J,358.3,32429,0)
- +46 ;;=H35.421^^128^1660^19
- +47 ;;^UTILITY(U,$J,358.3,32429,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,32429,1,3,0)
- +50 ;;=3^Microcystoid Degeneration or Retina,OD
- +51 ;;^UTILITY(U,$J,358.3,32429,1,4,0)
- +52 ;;=4^H35.421
- +53 ;;^UTILITY(U,$J,358.3,32429,2)
- +54 ;;=^5005675
- +55 ;;^UTILITY(U,$J,358.3,32430,0)
- +56 ;;=H35.422^^128^1660^20
- +57 ;;^UTILITY(U,$J,358.3,32430,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,32430,1,3,0)
- +60 ;;=3^Microcystoid Degeneration or Retina,OS
- +61 ;;^UTILITY(U,$J,358.3,32430,1,4,0)
- +62 ;;=4^H35.422
- +63 ;;^UTILITY(U,$J,358.3,32430,2)
- +64 ;;=^5005676
- +65 ;;^UTILITY(U,$J,358.3,32431,0)
- +66 ;;=H35.423^^128^1660^21
- +67 ;;^UTILITY(U,$J,358.3,32431,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,32431,1,3,0)
- +70 ;;=3^Microcystoid Degeneration or Retina,Bilateral
- +71 ;;^UTILITY(U,$J,358.3,32431,1,4,0)
- +72 ;;=4^H35.423
- +73 ;;^UTILITY(U,$J,358.3,32431,2)
- +74 ;;=^5005677
- +75 ;;^UTILITY(U,$J,358.3,32432,0)
- +76 ;;=H35.451^^128^1660^23
- +77 ;;^UTILITY(U,$J,358.3,32432,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,32432,1,3,0)
- +80 ;;=3^Secondary Pigmentary Degeneration,OD
- +81 ;;^UTILITY(U,$J,358.3,32432,1,4,0)
- +82 ;;=4^H35.451
- +83 ;;^UTILITY(U,$J,358.3,32432,2)
- +84 ;;=^5005687
- +85 ;;^UTILITY(U,$J,358.3,32433,0)
- +86 ;;=H35.452^^128^1660^24
- +87 ;;^UTILITY(U,$J,358.3,32433,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,32433,1,3,0)
- +90 ;;=3^Secondary Pigmentary Degeneration,OS
- +91 ;;^UTILITY(U,$J,358.3,32433,1,4,0)
- +92 ;;=4^H35.452
- +93 ;;^UTILITY(U,$J,358.3,32433,2)
- +94 ;;=^5005688
- +95 ;;^UTILITY(U,$J,358.3,32434,0)
- +96 ;;=H35.453^^128^1660^25
- +97 ;;^UTILITY(U,$J,358.3,32434,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,32434,1,3,0)
- +100 ;;=3^Secondary Pigmentary Degeneration,Bilateral
- +101 ;;^UTILITY(U,$J,358.3,32434,1,4,0)
- +102 ;;=4^H35.453
- +103 ;;^UTILITY(U,$J,358.3,32434,2)
- +104 ;;=^5005689
- +105 ;;^UTILITY(U,$J,358.3,32435,0)
- +106 ;;=H35.381^^128^1660^16
- +107 ;;^UTILITY(U,$J,358.3,32435,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,32435,1,3,0)
- +110 ;;=3^Toxic Maculopathy,OD
- +111 ;;^UTILITY(U,$J,358.3,32435,1,4,0)
- +112 ;;=4^H35.381
- +113 ;;^UTILITY(U,$J,358.3,32435,2)
- +114 ;;=^5005666
- +115 ;;^UTILITY(U,$J,358.3,32436,0)
- +116 ;;=H35.382^^128^1660^17
- +117 ;;^UTILITY(U,$J,358.3,32436,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,32436,1,3,0)
- +120 ;;=3^Toxic Maculopathy,OS